Veradermics MANE
NYSE MANE
$118.28 -2.95 (-2.43%)
As of: Oct 1, 2026 · 3:09 PM EDT

Veradermics (MANE) Liabilities and Shareholders Equity (2024 - 2026)

Updated

Veradermics (MANE) reported Liabilities and Shareholders Equity of $825.74 million for Q2 2026, up 107.8% from the prior quarter.

Analysis

Veradermics (MANE) Liabilities and Shareholders Equity (2024 - 2026) Analysis & Trends

At the end of FY2025, Veradermics posted Liabilities and Shareholders Equity of $152.62 million, up 174.8% from FY2024.

  • By year, Liabilities and Shareholders Equity came in at $55.54 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Veradermics 5.07 Bn 5.07 Bn - 825.74 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 825.74 Mn
Mar 31, 2026 397.36 Mn
Dec 31, 2025 152.62 Mn
Dec 31, 2024 55.54 Mn
API Access

Veradermics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=MANE&period=max&api_key=YOUR_API_KEY